Vanguard Group
RBOT

Vanguard Group’s Vicarious Surgical RBOT Stock Holding History

Vanguard Group’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$307K Sell
141,255
-2,033
-1% -$8.27K ﹤0.01% 4032
2025
Q3 		$790K Buy
143,288
+11,252
+9% +$86K ﹤0.01% 3848
2025
Q2 		$990K Hold
132,036
– – ﹤0.01% 3746
2025
Q1 		$866K Buy
132,036
+1,637
+1% +$19.3K ﹤0.01% 3758
2024
Q4 		$1.72M Hold
130,399
– – ﹤0.01% 3617
2024
Q3 		$741K Hold
130,399
– – ﹤0.01% 3862
2024
Q2 		$765K Sell
130,399
-18,969
-13% -$170K ﹤0.01% 3880
2024
Q1 		$1.35M Buy
149,368
+3,079
+2% +$36.7K ﹤0.01% 3713
2023
Q4 		$1.61M Buy
146,289
+19,187
+15% +$214K ﹤0.01% 3676
2023
Q3 		$2.25M Buy
127,102
+46,803
+58% +$1.7M ﹤0.01% 3540
2023
Q2 		$4.41M Buy
80,299
+1,342
+2% +$85.5K ﹤0.01% 3367
2023
Q1 		$5.38M Buy
78,957
+4,919
+7% +$382K ﹤0.01% 3274
2022
Q4 		$4.49M Buy
74,038
+393
+0.5% +$36.5K ﹤0.01% 3356
2022
Q3 		$7.4M Sell
73,645
-65
-0.1% -$7.57K ﹤0.01% 3103
2022
Q2 		$6.5M Buy
73,710
+20,621
+39% +$2.52M ﹤0.01% 3231
2022
Q1 		$8.06M Buy
53,089
+931
+2% +$173K ﹤0.01% 3267
2021
Q4 		$16.6M Buy
+52,158
New +$18.4M ﹤0.01% 2937

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group's RBOT Position: Q4 2025 in Review

Vanguard Group reduced its Vicarious Surgical (RBOT) stake by 1.4% in Q4 2025, selling an estimated $8.27K and leaving 141,255 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #4032.

Vanguard Group first reported a position in RBOT in Q4 2021 and has held it in 17 quarters since. The position peaked at $16.6M in Q4 2021. 36 funds tracked by Wall St. Rank hold RBOT as of Q4 2025.

  • Vanguard Group held 141,255 shares of Vicarious Surgical worth $307K as of Q4 2025.
  • Vanguard Group sold 2,033 Vicarious Surgical shares in Q4 2025, an estimated $8.27K.
  • Vicarious Surgical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4032 holding.
  • Vanguard Group first reported a position in Vicarious Surgical in Q4 2021 and has held it in 17 quarters since.
  • Vanguard Group's Vicarious Surgical position peaked at $16.6M in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.